Cancer drug combo shows promise for patients resistant to standard treatments
December 31, 2025
In a Fox News story about an OHSU discovery of a promising new drug combination to help people with acute myeloid leukemia, Jeffrey Tyner, Ph.D., says, “The data show that this drug regimen may be especially effective in patients whose tumors exhibit features that cause resistance to the current standard of care, frontline therapies.”